Ethris Competitors and Similar CompaniesClear all

Ambrx's competitors and similar companies include Ocugen and Asklepios BioPharmaceutical.

	Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.	Ocugen Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to treat eye diseases	Asklepios BioPharmaceutical Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein.
Founding Date	Founding Date 2003	Founding Date 2013	Founding Date 2001
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy
Locations	Locations San Diego, US HQ	Locations Malvern, US HQ	Locations Chapel Hill, US HQ Roslin, GB
Employees	Employees 70	Employees 84425% increase	Employees 5172% increase
Valuation ($)	Valuation ($) 1.8 b	Valuation ($) 292.1 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $7.4m (FY, 2022)	Revenue (est.) $4.4m (FY, 2025)	Revenue (est.) N/A
Net income	Net income ($78m) (FY, 2022)	Net income ($67.8m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 347.9m	Total funding raised N/A	Total funding raised $ 235m